Danaher Beats Q1 Estimates and Plans Masimo Acquisition
Danaher reported first-quarter 2026 adjusted EPS of $2.06 on $6.0 billion in revenue, beating estimates of $1.94 and $5.99 billion, respectively. Adjusted operating margin was 30.2%, above the 28.3% estimate.
The company said adjusted diluted EPS rose 9.5% year over year, revenue increased 3.5% and core revenue grew 0.5%. Danaher also said it intends to acquire Masimo and reported operating cash flow of $1.3 billion and non-GAAP free cash flow of $1.1 billion.
From the sources (3 posts)
@firstsquawkDANAHER Q1 2026 EARNINGS: ADJ EPS $2.06 (EST $1.94) || SALES $6.0B (EST $5.99B) || BIOTECHNOLOGY REV $1.80B (EST $1.79B) || DIAGNOSTICS REV $2.42B (EST $2.49B) || LIFE SCIENCES REV. $1.74B (EST $1.13B) || ADJ. OPER MARGIN 30.2% (EST 28.3%)
@alphasenseinc$DHR Earnings: - Net earnings were $1.0 billion, or $1.45 per diluted common share. - Non-GAAP adjusted diluted net earnings per common share grew 9.5% to $2.06. - Revenues increased 3.5% year-over-year to $6.0 billion and non-GAAP core re
@thetranscript_Danaher Q1 2026: —Revenue: +3.5% to $6.0B (Core: +0.5%, FX: +3.0%) —Operating Profit: +5.5% to $1.34B —Net Earnings: +7.9% to $1.03B —Operating Cash Flow: +1.8% to $1.32B —FCF: +2.5% to $1.09B CEO: "Our team executed well in the first qua